Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin
* Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin. * Global and regional deal to be initiated. * PT105 represents Korea's first commercialized generic drug of Leuplin, applied with SmartDepot technology. * Development of 3- and 6-month...
2022-11-28 09:00
3067
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
SEOUL, South Korea and JINAN, China, April 16, 2021 /PRNewswire/ -- Peptron, Inc. ("Peptron", KOSDAQ: 087010), aSouth Korea-based biotech company, and Qilu Pharmaceutical ("Qilu"), a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and commerc...
2021-04-16 20:00
4007
